Organization Overview
Alternative names
betamethasone (celestone) (1 trial)
ceftaroline fosamil (teflaro) (1 trial)
ceftriaxone (rocephin) (1 trial)
dexmedetomidine (precedex) (1 trial)
dicloxacillin (pathocil) (1 trial)
diltiazem (cardizem) (1 trial)
dorzolamide (trusopt) (1 trial)
glycopyrronium (robinul) (2 trials)
latanoprost (xalatan) (1 trial)
levofloxacin (levaquin) (1 trial)
Acute Kidney Injury (Phase 4)
Adrenal Insufficiency (Phase 4)
Alzheimer Disease (Phase 2)
Atrial Fibrillation (Phase 4)
Atrial Flutter (Phase 4)
Biliary Dyskinesia (Phase 2)
Breast Neoplasms (Phase 2)
Bronchopulmonary Dysplasia (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Central Nervous System Neoplasms (Phase 1)
Chronic Pain (Phase 4)
Cognitive Dysfunction (Phase 1)
Colonic Neoplasms (Phase 1)
Communicable Diseases (Phase 3)
Coronary Artery Disease (Phase 4)
Coronavirus Infections (Phase 4)
Cystic Fibrosis (Phase 4)
Deglutition Disorders (Phase 4)
Dyskinesias (Phase 2)
Exanthema (Phase 2)
Fibrosis (Phase 4)
Fractures, Bone (Phase 4)
Glaucoma (Phase 4)
Glaucoma, Open-Angle (Phase 4)
Glioblastoma (Phase 1)
Graft vs Host Disease (Phase 2)
Hand-Foot Syndrome (Phase 1)
Head and Neck Neoplasms (Phase 1)
Hypotension (Phase 4)
Infections (Phase 4)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 2)
Lung Diseases (Phase 3)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 3)
Lymphoma, Follicular (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Mucositis (Phase 2)
Multiple Sclerosis (Phase 3)
Neoplasms (Phase 2)
Neoplastic Cells, Circulating (Phase 1)
Nervous System Neoplasms (Phase 1)
Neurotoxicity Syndromes (Phase 2)
Opioid-Related Disorders (Phase 3)
Paralysis (Phase 4)
RNA Virus Infections (Phase 3)
Sclerosis (Phase 3)
Sepsis (Phase 4)
Severe Acute Respiratory Syndrome (Phase 4)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Staphylococcal Infections (Phase 4)
Toxemia (Phase 4)
Urinary Bladder Neoplasms (Phase 2)
Virus Diseases (Phase 3)
Wound Infection (Phase 4)
Wounds and Injuries (Phase 4)